Experienced in Gout

Dr. Qaiser Rehman

Select Physical Therapy Texas Limited Partnership
Houston, TX
Experienced
in Gout
Specialties:Rheumatology
Accepting New Patients
Offers Telehealth
OverviewInsuranceLocationsClinical Research

Overview

Qaiser Rehman is a Rheumatologist in Houston, Texas. Dr. Rehman and is rated as an Experienced provider by MediFind in the treatment of Gout. His top areas of expertise are Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, Osteoporosis, and Ankylosing Spondylitis. Dr. Rehman is currently accepting new patients.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in TX
Hospital Affiliations
Houston Methodist Willowbrook Hospital
Languages Spoken
English
Hindi
Spanish
Urdu
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Community Health
  •  Blue Cross Blue Shield
  •  Friday Health
  •  Humana

Locations

SELECT PHYSICAL THERAPY TEXAS LIMITED PARTNERSHIP
17270 Red Oak Dr, Suite 180, Houston, TX 77090
281-440-7625
Other Locations
11307 Fm 1960 Rd W, Suite 240, Houston, TX 77065

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
8
conditions
Dr. Prashanth R. Sunkureddi
Rheumatology
Expertise in
8
conditions
Dr. Prashanth R. Sunkureddi
Rheumatology

Prashanth R. Sunkureddi, M.D., P.A.

3725 E League City Pkwy, Suite 200, 
League City, TX 
 (43.2 mi)
281-957-9127
Languages Spoken:
English
See accepted insurances

Prashanth Sunkureddi is a Rheumatologist in League City, Texas. Dr. Sunkureddi and is rated as an Advanced provider by MediFind in the treatment of Gout. His top areas of expertise are Arthritis, Gout, Rheumatoid Arthritis (RA), and Psoriatic Arthritis.

Expertise in
14
conditions
Dr. Asif Cochinwala
Rheumatology
Expertise in
14
conditions
Dr. Asif Cochinwala
Rheumatology
1631 N Loop W, Suite 480, 
Houston, TX 
 (14.6 mi)
832-237-0400
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Asif Cochinwala is a Rheumatologist in Houston, Texas. Dr. Cochinwala and is rated as an Advanced provider by MediFind in the treatment of Gout. His top areas of expertise are Rheumatoid Arthritis (RA), Sjogren Syndrome, Undifferentiated Connective Tissue Disease (UCTD), and Interstitial Keratitis. Dr. Cochinwala is currently accepting new patients.

Expertise in
4
conditions
Dr. Jasvinder Singh
Rheumatology
Expertise in
4
conditions
Dr. Jasvinder Singh
Rheumatology

Baylor College Of Medicine

7200 Cambridge St, Fl 10, 
Houston, TX 
 (22.5 mi)
713-798-1000
Languages Spoken:
English, Hindi, Punjabi
See accepted insurances
Accepting New Patients

Jasvinder Singh is a Rheumatologist in Houston, Texas. Dr. Singh and is rated as an Advanced provider by MediFind in the treatment of Gout. His top areas of expertise are Gout, Mixed Connective Tissue Disease, MASS Phenotype, and Bursitis. Dr. Singh is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile